Literature DB >> 23101029

Nestin overexpression precedes caspase-3 upregulation in rats exposed to controlled cortical impact traumatic brain injury.

Yuji Kaneko1, Naoki Tajiri, Seongjin Yu, Takuro Hayashi, Christine E Stahl, Eunkyung Bae, Humberto Mestre, Nicholas Franzese, Antonio Rodrigues, Maria C Rodrigues, Hiroto Ishikawa, Kazutaka Shinozuka, Whitney Hethorn, Nathan Weinbren, Loren E Glover, Jun Tan, Anilkumar Harapanahalli Achyuta, Harry van Loveren, Paul R Sanberg, Sundaram Shivsankar, Cesar V Borlongan.   

Abstract

Our understanding of biological mechanisms and treatment options for traumatic brain injury (TBI) is limited. Here, we employed quantitative real-time PCR (QRT-PCR) and immunohistochemical analyses to determine the dynamic expression of cell proliferation and apoptosis in an effort to provide insights into the therapeutic window for developing regenerative strategies for TBI. For this purpose, young adult Sprague-Dawley rats were subjected to experimental TBI using a controlled cortical impactor, then euthanized 1-48 hours after TBI for QRT-PCR and immunohistochemistry. QRT-PCR revealed that brains from TBI exposed rats initially displayed nestin mRNA expression that modestly increased as early as 1-hour post-TBI, then significantly peaked at 8 hours, but thereafter reverted to pre-TBI levels. On the other hand, caspase-3 mRNA expression was slightly elevated at 8 hours post-TBI, which did not become significantly upregulated until 48 hours. Immunofluorescent microscopy revealed a significant surge in nestin immunoreactive cells in the cortex, corpus callosum, and subventricular zone at 24 hours post-TBI, whereas a significant increase in the number of active caspase-3 immunoreactive cells was only found in the cortex and not until 48 hours. These results suggest that the injured brain attempts to repair itself via cell proliferation immediately after TBI, but that this endogenous regenerative mechanism is not sufficient to abrogate the secondary apoptotic cell death. Treatment strategies designed to amplify cell proliferation and to prevent apoptosis are likely to exert maximal benefits when initiated at the acute phase of TBI.

Entities:  

Year:  2012        PMID: 23101029      PMCID: PMC3478780          DOI: 10.3727/215517912x639306

Source DB:  PubMed          Journal:  Cell Med        ISSN: 2155-1790


  48 in total

Review 1.  Reactive astrocytes: cellular and molecular cues to biological function.

Authors:  J L Ridet; S K Malhotra; A Privat; F H Gage
Journal:  Trends Neurosci       Date:  1997-12       Impact factor: 13.837

2.  Expression of Fas and Fas ligand after experimental traumatic brain injury in the rat.

Authors:  R Beer; G Franz; M Schöpf; M Reindl; B Zelger; E Schmutzhard; W Poewe; A Kampfl
Journal:  J Cereb Blood Flow Metab       Date:  2000-04       Impact factor: 6.200

3.  Expression of nestin after traumatic brain injury in rat brain.

Authors:  S Sahin Kaya; A Mahmood; Y Li; E Yavuz; M Chopp
Journal:  Brain Res       Date:  1999-09-04       Impact factor: 3.252

4.  Effect of granulocyte colony-stimulating factor on functional and histopathologic outcome after traumatic brain injury in mice.

Authors:  Negar Sheibani; Eric F Grabowski; David A Schoenfeld; Michael J Whalen
Journal:  Crit Care Med       Date:  2004-11       Impact factor: 7.598

Review 5.  Erythropoietin as a neuroprotective agent in traumatic brain injury Review.

Authors:  Antonios Mammis; Tracy K McIntosh; Allen H Maniker
Journal:  Surg Neurol       Date:  2008-09-11

6.  Disruption of Bax protein prevents neuronal cell death but produces cognitive impairment in mice following traumatic brain injury.

Authors:  Roya Tehranian; Marie E Rose; Vincent Vagni; Alicia M Pickrell; Raymond P Griffith; Hao Liu; Robert S B Clark; C Edward Dixon; Patrick M Kochanek; Steven H Graham
Journal:  J Neurotrauma       Date:  2008-07       Impact factor: 5.269

7.  Neural progenitor cell transplants promote long-term functional recovery after traumatic brain injury.

Authors:  Deborah A Shear; Matthew C Tate; David R Archer; Stuart W Hoffman; Verne D Hulce; Michelle C Laplaca; Donald G Stein
Journal:  Brain Res       Date:  2004-11-05       Impact factor: 3.252

8.  Necrostatin-1 reduces histopathology and improves functional outcome after controlled cortical impact in mice.

Authors:  Zerong You; Sean I Savitz; Jinsheng Yang; Alexei Degterev; Junying Yuan; Gregory D Cuny; Michael A Moskowitz; Michael J Whalen
Journal:  J Cereb Blood Flow Metab       Date:  2008-05-21       Impact factor: 6.200

9.  Characterization of the pharmacokinetics of human recombinant erythropoietin in blood and brain when administered immediately after lateral fluid percussion brain injury and its pharmacodynamic effects on IL-1beta and MIP-2 in rats.

Authors:  Thomas Lieutaud; Peter J D Andrews; Jonathan K J Rhodes; Robert Williamson
Journal:  J Neurotrauma       Date:  2008-10       Impact factor: 5.269

10.  Turning astrocytes from the rostral migratory stream into neurons: a role for the olfactory sensory organ.

Authors:  Mariana Alonso; Inmaculada Ortega-Pérez; Matthew S Grubb; Jean-Pierre Bourgeois; Pierre Charneau; Pierre-Marie Lledo
Journal:  J Neurosci       Date:  2008-10-22       Impact factor: 6.167

View more
  10 in total

1.  Diabetes insipidus contributes to traumatic brain injury pathology via CD36 neuroinflammation.

Authors:  Theo Diamandis; Chiara Gonzales-Portillo; Gabriel S Gonzales-Portillo; Meaghan Staples; Mia C Borlongan; Diana Hernandez; Sandra Acosta; Cesar V Borlongan
Journal:  Med Hypotheses       Date:  2013-08-30       Impact factor: 1.538

Review 2.  Stem cells and G-CSF for treating neuroinflammation in traumatic brain injury: aging as a comorbidity factor.

Authors:  I Dela Peña; P R Sanberg; S Acosta; N Tajiri; S Z Lin; C V Borlongan
Journal:  J Neurosurg Sci       Date:  2014-05-20       Impact factor: 2.279

3.  Transcranial low-level laser therapy enhances learning, memory, and neuroprogenitor cells after traumatic brain injury in mice.

Authors:  Weijun Xuan; Fatma Vatansever; Liyi Huang; Michael R Hamblin
Journal:  J Biomed Opt       Date:  2014       Impact factor: 3.170

4.  Suppressed cytokine expression immediatey following traumatic brain injury in neonatal rats indicates an expeditious endogenous anti-inflammatory response.

Authors:  Naoki Tajiri; Diana Hernandez; Sandra Acosta; Kazutaka Shinozuka; Hiroto Ishikawa; Jared Ehrhart; Theo Diamandis; Chiara Gonzales-Portillo; Mia C Borlongan; Jun Tan; Yuji Kaneko; Cesar V Borlongan
Journal:  Brain Res       Date:  2014-03-03       Impact factor: 3.252

5.  Rapid manifestation of reactive astrogliosis in acute hippocampal brain slices.

Authors:  Takahiro Takano; Wei He; Xiaoning Han; Fushun Wang; Qiwu Xu; Xiaohai Wang; Nancy Ann Oberheim Bush; Nancy Cruz; Gerald A Dienel; Maiken Nedergaard
Journal:  Glia       Date:  2013-11-06       Impact factor: 7.452

Review 6.  The Controlled Cortical Impact Model: Applications, Considerations for Researchers, and Future Directions.

Authors:  Nicole D Osier; C Edward Dixon
Journal:  Front Neurol       Date:  2016-08-17       Impact factor: 4.003

Review 7.  Hyperbaric oxygen therapy as a potential treatment for post-traumatic stress disorder associated with traumatic brain injury.

Authors:  David J Eve; Martin R Steele; Paul R Sanberg; Cesar V Borlongan
Journal:  Neuropsychiatr Dis Treat       Date:  2016-10-20       Impact factor: 2.570

8.  Endothelial Progenitor Cells Modulate Inflammation-Associated Stroke Vasculome.

Authors:  Sandra A Acosta; Jea Y Lee; Hung Nguyen; Yuji Kaneko; Cesar V Borlongan
Journal:  Stem Cell Rev Rep       Date:  2019-04       Impact factor: 5.739

9.  Brain Region-Specific Histopathological Effects of Varying Trajectories of Controlled Cortical Impact Injury Model of Traumatic Brain Injury.

Authors:  Mibel M Pabón; Sandra Acosta; Vivian A Guedes; Naoki Tajiri; Yuji Kaneko; Cesar V Borlongan
Journal:  CNS Neurosci Ther       Date:  2016-01-18       Impact factor: 5.243

Review 10.  Cell therapy for central nervous system disorders: Current obstacles to progress.

Authors:  Takao Yasuhara; Satoshi Kawauchi; Kyohei Kin; Jun Morimoto; Masahiro Kameda; Tatsuya Sasaki; Brooke Bonsack; Chase Kingsbury; Naoki Tajiri; Cesario V Borlongan; Isao Date
Journal:  CNS Neurosci Ther       Date:  2019-10-17       Impact factor: 5.243

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.